| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.0009 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |